Testing an oral supplement for diabetic nerve pain
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests a capsule (DLBS1033) to see if it can relieve pain and improve nerve function in people with diabetic polyneuropathy. It may help reduce the numbness or tingling caused by long-term diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with diabetic polyneuropathy (nerve damage from diabetes)
- Between 40 and 60 years old
- HbA1c (average blood sugar) within the last 30 days is between 7% and 10%
- Willing to sign a consent form and attend study visits
- Not pregnant, breastfeeding, or planning pregnancy
- No other major nerve or brain conditions (e.g., stroke, spinal cord disease, or alcohol-related nerve damage)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a spinal cord stimulator can reduce pain from diabetic nerve damage in the legs. It focuses on people with long-lasting type 2 diabetes and significant, treatment-resistant pain.
This study tests an experimental medicine called DLBS1033 (a natural supplement) added to your usual treatment for diabetic nerve pain. It aims to see if it improves symptoms and quality of life.
This study tests an investigational medicine (HL-1186) to see if it can reduce nerve pain caused by diabetes. If you have had burning or shooting pain in your feet or legs for at least 6 months, this trial might help find a new way to ease that pain.
This trial tests if Levagen+ (a supplement) can reduce nerve pain caused by diabetes. It is for people with type 1 or type 2 diabetes who have significant nerve pain in their feet or legs.
This trial tests an investigational drug for people with pain caused by nerve damage from diabetes (diabetic peripheral neuropathy). It may help reduce pain in your lower legs if other treatments haven't worked well.
This Phase 3 study tests Praga formulation to see if it safely reduces nerve pain caused by diabetes. You may qualify if you’re an adult with painful diabetic neuropathy and have certain symptom and pain scores on questionnaires.
Hear when a new Diabetic Polyneuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.